Indications and medication precautions for Xiidra in Switzerland
Xiidra is an ophthalmic solution used to treat dry eye syndrome. Its indications are mainly moderate to severe dry eye related ocular surface inflammation. When using it, attention should be paid to monitoring and managing adverse reactions such as eye irritation and allergic reactions. Special populations need to adjust their medication regimen.
Indications for Rituximab
(1) Main indications
Suitable for treating ocular surface inflammation and symptoms in patients with dry eye syndrome, by inhibiting the interaction between lymphocyte function associated antigen-1 (LFA-1) and intercellular adhesion molecule-1 (ICAM-1), the inflammatory response is reduced.
(2) Applicable population
Mainly used for the treatment of moderate to severe dry eye syndrome in adult patients aged 18 and above, it can improve the symptoms and signs of eye discomfort, such as burning sensation, foreign body sensation, and visual fluctuations.
2. Precautions for the use of Rituximab
(1) Usage method
Twice a day, one drop each time, with an interval of about 12 hours. Wash hands before use and avoid contact between the bottle mouth and eyes or any surface to prevent contamination.
(2) Adverse reaction monitoring
Common eye irritation symptoms such as burning and stinging are usually mild and brief. If severe eye pain, visual changes, or allergic reactions occur, the medication should be stopped immediately and medical attention sought.
(3) Precautions for special populations
Pregnant and lactating women need to weigh the pros and cons when using it. Elderly patients may be more prone to eye discomfort and require close monitoring. Those who wear contact lenses should wear them 15 minutes after taking the medication.
(4) Drug interactions
When combined with other eye medications, there should be at least a 5-minute interval. Eye drops containing preservatives may exacerbate irritation, and it is recommended to prioritize formulations without preservatives.
(5) Storage conditions
Refrigerate unopened (2-8 ° C), store at room temperature (not exceeding 25 ° C) after opening, and discard after 6 weeks. Avoid direct sunlight and high temperature environments.
Disclaimer：《Indications and medication precautions for Xiidra in Switzerland》Edited and sorted by Seagull Pharmacy's editors. Please contact us in time if there is any infringement. In addition, the suggestions for drug usage, dosage and disease mentioned in the article are only for medical staff's reference, and can not be used as any basis for medication！